Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Wan-Rong Yi, Mei-Juan Tu, Ai-Xi Yu, Jun Lin & Ai-Ming Yu. (2022) Bioengineered miR-34a modulates mitochondrial inner membrane protein 17 like 2 (MPV17L2) expression toward the control of cancer cell mitochondrial functions. Bioengineered 13:5, pages 12489-12503.
Read now
Read now
Tuhin Das, Tushar Kanti Das, Anne Khodarkovskaya & Sabyasachi Dash. (2021) Non-coding RNAs and their bioengineering applications for neurological diseases. Bioengineered 12:2, pages 11675-11698.
Read now
Read now
Fucheng Zhao, Zhenxia Zhao, Yanru Han, Sujuan Li, Caili Liu & Kui Jia. (2021) Baicalin suppresses lung cancer growth phenotypes via miR-340-5p/NET1 axis. Bioengineered 12:1, pages 1699-1707.
Read now
Read now
Ming-Yu Chen, Kai Fan, Lian-Jiang Zhao, Jie-Mei Wei, Ji-Xu Gao & Zhen-Fu Li. (2021) Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) sponges microRNA-124-3p to up-regulate phosphodiesterase 4B (PDE4B) to accelerate the progression of Parkinson’s disease. Bioengineered 12:1, pages 708-719.
Read now
Read now
Longying Chen, Dianlong Zhang, Li Yu & He Dong. (2019) Targeting MIAT reduces apoptosis of cardiomyocytes after ischemia/reperfusion injury. Bioengineered 10:1, pages 121-132.
Read now
Read now
Articles from other publishers (15)
Fatemeh Rafieenia, Seyed Omar Ebrahimi, Ensieh sadat Emadi, Forough Taheri & Somayeh Reiisi. (2023)
Bioengineered chimeric
tRNA
/
pre‐miRNAs
as prodrugs in cancer therapy
. Biotechnology Progress.
Crossref
Crossref
Mathieu Guerriaud & Evelyne Kohli. (2022) RNA-based drugs and regulation: Toward a necessary evolution of the definitions issued from the European union legislation. Frontiers in Medicine 9.
Crossref
Crossref
Ye Tian, Chong Yin, Chaofei Yang, Mili Ji, Xiaohua Chu & Airong Qian. 2021. Noncoding RNAs and Bone. Noncoding RNAs and Bone
141
157
.
Atieh Hashemi & Gilar Gorji-bahri. (2020) MicroRNA: Promising Roles in Cancer Therapy. Current Pharmaceutical Biotechnology 21:12, pages 1186-1203.
Crossref
Crossref
Nihay Laham-Karam, Gaspar P. Pinto, Antti Poso & Piia Kokkonen. (2020) Transcription and Translation Inhibitors in Cancer Treatment. Frontiers in Chemistry 8.
Crossref
Crossref
Ai-Ming Yu, Neelu Batra, Mei-Juan Tu & Colleen Sweeney. (2020) Novel approaches for efficient in vivo fermentation production of noncoding RNAs. Applied Microbiology and Biotechnology 104:5, pages 1927-1937.
Crossref
Crossref
Wanrong Yi, Mei-Juan Tu, Zhenzhen Liu, Chao Zhang, Neelu Batra, Ai-Xi Yu & Ai-Ming Yu. (2020) Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics. Acta Pharmaceutica Sinica B 10:1, pages 159-170.
Crossref
Crossref
Yu-Ting Shao, Li Ma, Tie-Hui Zhang, Tian-Rui Xu, Yuan-Chao Ye & Ying Liu. (2019) The Application of the RNA Interference Technologies for KRAS: Current Status, Future Perspective and Associated Challenges. Current Topics in Medicinal Chemistry 19:23, pages 2143-2157.
Crossref
Crossref
Yuhua Li, Qiang Meng, Mengbi Yang, Dongyang Liu, Xiangyu Hou, Lan Tang, Xin Wang, Yuanfeng Lyu, Xiaoyan Chen, Kexin Liu, Ai-Ming Yu, Zhong Zuo & Huichang Bi. (2019) Current trends in drug metabolism and pharmacokinetics. Acta Pharmaceutica Sinica B 9:6, pages 1113-1144.
Crossref
Crossref
Ai-Ming Yu, Chao Jian, Allan H. Yu & Mei-Juan Tu. (2019) RNA therapy: Are we using the right molecules?. Pharmacology & Therapeutics 196, pages 91-104.
Crossref
Crossref
Qian-Yu Zhang, Pui Yan Ho, Mei-Juan Tu, Joseph L. Jilek, Qiu-Xia Chen, Su Zeng & Ai-Ming Yu. (2018) Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivo. International Journal of Pharmaceutics 547:1-2, pages 537-544.
Crossref
Crossref
Lorenzo Baronti, Hampus Karlsson, Maja Marušič & Katja Petzold. (2018) A guide to large-scale RNA sample preparation. Analytical and Bioanalytical Chemistry 410:14, pages 3239-3252.
Crossref
Crossref
Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, Joseph L. Jilek, Zhijian Duan, Qian-Yu Zhang, Ai-Xi Yu & Ai-Ming Yu. (2018) Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells. Drug Metabolism and Disposition 46:1, pages 2-10.
Crossref
Crossref
Chao Jian, Mei-Juan Tu, Pui Yan Ho, Zhijian Duan, Qianyu Zhang, Jing-Xin Qiu, Ralph W. DeVere White, Theodore Wun, Primo N. Lara, Kit S. Lam, Ai-Xi Yu & Ai-Ming Yu. (2017) Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models. Oncotarget 8:19, pages 30742-30755.
Crossref
Crossref
Joseph L. Jilek, Ye Tian & Ai-Ming Yu. (2017) Effects of MicroRNA-34a on the Pharmacokinetics of Cytochrome P450 Probe Drugs in Mice. Drug Metabolism and Disposition 45:5, pages 512-522.
Crossref
Crossref